Dali Pharmaceutical Co (SHSE:603963) Ending Cash Position : ¥207.69 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co Ending Cash Position?

Dali Pharmaceutical Co's Ending Cash Position for the quarter that ended in Sep. 2024 was ¥207.69 Mil.

Dali Pharmaceutical Co's quarterly Ending Cash Position increased from Mar. 2024 (¥39.68 Mil) to Jun. 2024 (¥139.41 Mil) and increased from Jun. 2024 (¥139.41 Mil) to Sep. 2024 (¥207.69 Mil).

Dali Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (¥180.66 Mil) to Dec. 2022 (¥43.84 Mil) and declined from Dec. 2022 (¥43.84 Mil) to Dec. 2023 (¥14.19 Mil).

Dali Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Dali Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dali Pharmaceutical Co Ending Cash Position Chart

Dali Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

82.63

63.33

180.66

43.84

14.19

Dali Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															16.57	14.19	39.68	139.41	207.69

Dali Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Dali Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	43.839	+	-29.645
	=	14.19

Dali Pharmaceutical Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	139.405	+	68.283
	=	207.69

Dali Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Dali Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000

Website

http://www.daliyaoye.cn

Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.

Executives

Wu Pei Rong	senior management
Yang Jun Xiang	Directors, senior managers
Yang Jun Wei	Director

Dali Pharmaceutical Co Headlines

No Headlines